Veradigm Inc.

OTCPK:MDRX 株式レポート

時価総額:US$1.8b

Veradigm マネジメント

マネジメント 基準チェック /24

Veradigmの CEO はTom Langanで、 May2022年に任命され、 の在任期間は 2.5年です。 は、会社の株式の0.2%を直接所有しており、その価値は$ 3.54M 。経営陣と取締役会の平均在任期間はそれぞれ3.8年と6.5年です。

主要情報

Tom Langan

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間2.5yrs
CEOの所有権0.2%
経営陣の平均在職期間3.8yrs
取締役会の平均在任期間6.5yrs

経営陣の近況

Recent updates

Veradigm (NASDAQ:MDRX) Is Doing The Right Things To Multiply Its Share Price

Feb 28
Veradigm (NASDAQ:MDRX) Is Doing The Right Things To Multiply Its Share Price

Veradigm (NASDAQ:MDRX) Might Have The Makings Of A Multi-Bagger

Nov 10
Veradigm (NASDAQ:MDRX) Might Have The Makings Of A Multi-Bagger

Veradigm's (NASDAQ:MDRX) Returns On Capital Are Heading Higher

Mar 06
Veradigm's (NASDAQ:MDRX) Returns On Capital Are Heading Higher

Is It Too Late To Consider Buying Veradigm Inc. (NASDAQ:MDRX)?

Feb 13
Is It Too Late To Consider Buying Veradigm Inc. (NASDAQ:MDRX)?

Veradigm Inc. (NASDAQ:MDRX) Shares Could Be 47% Below Their Intrinsic Value Estimate

Jan 22
Veradigm Inc. (NASDAQ:MDRX) Shares Could Be 47% Below Their Intrinsic Value Estimate

These 4 Measures Indicate That Veradigm (NASDAQ:MDRX) Is Using Debt Reasonably Well

Jan 04
These 4 Measures Indicate That Veradigm (NASDAQ:MDRX) Is Using Debt Reasonably Well

Returns Are Gaining Momentum At Allscripts Healthcare Solutions (NASDAQ:MDRX)

Dec 03
Returns Are Gaining Momentum At Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare reaffirms 2022 financial guidance; shares fall 2%

Sep 28

Should You Think About Buying Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Now?

Sep 17
Should You Think About Buying Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Now?

Investors Will Want Allscripts Healthcare Solutions' (NASDAQ:MDRX) Growth In ROCE To Persist

Aug 24
Investors Will Want Allscripts Healthcare Solutions' (NASDAQ:MDRX) Growth In ROCE To Persist

We Think Allscripts Healthcare Solutions (NASDAQ:MDRX) Is Taking Some Risk With Its Debt

Jul 31
We Think Allscripts Healthcare Solutions (NASDAQ:MDRX) Is Taking Some Risk With Its Debt

Is Now An Opportune Moment To Examine Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)?

Jun 15
Is Now An Opportune Moment To Examine Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)?

We Like These Underlying Return On Capital Trends At Allscripts Healthcare Solutions (NASDAQ:MDRX)

May 03
We Like These Underlying Return On Capital Trends At Allscripts Healthcare Solutions (NASDAQ:MDRX)

CEO(最高経営責任者

Tom Langan (58 yo)

2.5yrs

在職期間

Mr. Thomas J. Langan, also known as Tom, serves as CEO of Veradigm Inc. since June 7, 2024. He serves as President at Veradigm Inc. (formerly known as Allscripts Healthcare Solutions, Inc.) since May 06, 2...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
P. Garrison
Executive Chairman of the Board9.3yrsUS$303.00k0.044%
$ 804.3k
Tejal Vakharia
Senior VP of Marketing & Government Affairs4.4yrsUS$2.08m0.12%
$ 2.2m
Thomas Langan
President & Chief Commercial Officer and Interim CEO2.5yrsデータなし0.20%
$ 3.5m
Leland Westerfield
Interim CFO and Principal Financial & Accounting Officerless than a yearデータなしデータなし
Jenny Gelinas
Vice President of Investor Relations3.8yrsデータなしデータなし
Richard Elmore
Senior Vice President of Corporate Development & Strategy5.8yrsデータなしデータなし
Lisa Hammond
Senior VP & Chief Human Resources Officer3.5yrsデータなし0.015%
$ 265.3k
John Sage
Senior Vice President of U.S. Hospitals & Health Systems Sales9.9yrsデータなしデータなし
Elliot Bryant
Senior VP & General Manager for Classic Client Solutions Business Unit4.3yrsデータなしデータなし
John Mayr
Senior Vice President of Global Client Delivery Organization2.8yrsデータなしデータなし
Alan Fowles
President of Allscripts International7.8yrsデータなしデータなし
Eric Jacobson
Senior VP & Corporate Secretaryno dataデータなしデータなし

3.8yrs

平均在職期間

54yo

平均年齢

経験豊富な経営陣: MDRXの経営陣は 経験豊富 であると考えられます ( 3.8年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
P. Garrison
Executive Chairman of the Board9.3yrsUS$303.00k0.044%
$ 804.3k
Jonathan Judge
Independent Director8.5yrsUS$301.00k0.091%
$ 1.6m
Carol Zierhoffer
Lead Independent Director4.3yrsUS$277.50k0.037%
$ 675.1k
David Stevens
Independent Director8.5yrsUS$281.50k0.032%
$ 569.7k
Kim Franks
Member of Advisory Boardno dataデータなしデータなし
Elizabeth Altman
Independent Director4.4yrsUS$277.50k0.033%
$ 603.5k
Susan Rodriguez
Director1.8yrsデータなし0.012%
$ 224.5k
Jeanne Armstrong
Member of Advisory Boardno dataデータなしデータなし
Geoff Caplea
Member of Advisory Boardno dataデータなしデータなし
Laura Kohlhagen
Member of Advisory Boardno dataデータなしデータなし
Debbie McKay
Member of Advisory Boardno dataデータなしデータなし
Ramanujam Venugopalan
Member of Advisory Boardno dataデータなしデータなし

6.5yrs

平均在職期間

62.5yo

平均年齢

経験豊富なボード: MDRXの 取締役会経験豊富 であると考えられます ( 6.5年の平均在任期間)。